— Know what they know.
Not Investment Advice

219A.T JPX

Heartseed, Inc.
1W: -4.4% 1M: +4.1% 3M: +54.6% YTD: +35.2% 1Y: -24.3%
¥2,700.00 ($17.11)
+121.00 (+4.69%)
 
Weekly Expected Move ±8.1%
¥2161 ¥2370 ¥2579 ¥2788 ¥2997
JPX · Healthcare · Biotechnology · Tech Score Strong Buy · Power 68 · ¥59.0B mcap · 12M float · 3.03% daily turnover

Balance Sheet Trends

Total Assets
$8.1B +15.2% ▲
3Y CAGR: +18.1%
Total Liabilities
$571M +28.6% ▲
3Y CAGR: +39.9%
Shareholders Equity
$7.6B +14.3% ▲
3Y CAGR: +17.0%
Cash & Investments
$7.3B +38.6% ▲
3Y CAGR: +22.5%
Total Debt
$890K -83.5% ▼
3Y CAGR: -69.4%
Net Debt
-$7.3B -38.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$4.0B$4.6B$5.3B$7.3B
Short-Term Investments$0$0$0$0
Cash & ST Investments$4.0B$4.6B$5.3B$7.3B
Net Receivables$518M$214M$798M$157M
Inventory$91M$137M$86M$25M
Other Current Assets$1K$2K$139M$4K
Total Current Assets$4.9B$5.0B$6.4B$7.6B
Property, Plant & Equip.$7M$484M$456M$439M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$6M$208M$208M$0
Other Non-Current Assets$4M$0$0$101M
Total Non-Current Assets$17M$692M$664M$540M
Total Assets$4.9B$5.7B$7.1B$8.1B
— Liabilities —
Accounts Payable$0$0$81M$0
Short-Term Debt$19M$6M$5M$890K
Deferred Revenue$0$0$0$0
Other Current Liabilities$101M$229M$138M$265M
Total Current Liabilities$142M$244M$282M$411M
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$54M$186M$158M$160M
Total Non-Current Liabilities$66M$206M$162M$160M
Total Liabilities$208M$450M$444M$571M
— Equity —
Common Stock$50M$50M$1.1B$1.3B
Retained Earnings-$1.5B-$3.0B-$2.8B-$2.2B
Accumulated OCI$13M$13M$12M$5M
Total Stockholders Equity$4.7B$5.3B$6.6B$7.6B
Total Liabilities & Equity$4.9B$5.7B$7.1B$8.1B
— Key Metrics —
Total Debt$31M$12M$5M$890K
Net Debt-$4.0B-$4.6B-$5.3B-$7.3B
Total Investments$6M$208M$208M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms